Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 30;122(39):e2506437122.
doi: 10.1073/pnas.2506437122. Epub 2025 Sep 23.

Muscle-specific increased expression of JAG1 improves the skeletal muscle phenotype in dystrophin-deficient mice

Affiliations

Muscle-specific increased expression of JAG1 improves the skeletal muscle phenotype in dystrophin-deficient mice

Felipe de Souza Leite et al. Proc Natl Acad Sci U S A. .

Abstract

Therapeutic strategies for Duchenne muscular dystrophy (DMD) will likely require complementary approaches. One possibility is to explore genetic modifiers that improve muscle regeneration and function. The beneficial effects of the overexpression of Jagged-1 were described in escaper golden retriever muscular dystrophy (GRMD) dogs that had a near-normal life and validated in dystrophin-deficient zebrafish. To clarify the underlying biology of JAG1 overexpression in dystrophic muscles, we generated a transgenic mouse (mdx5cv-JAG1) model that lacks dystrophin and overexpresses human JAG1 in striated muscles. Skeletal muscles from mdx5cv-JAG1 and mdx5cv mice were studied at 1-, 4-, and 12-mo time points. JAG1 expression in mdx5cv-JAG1 increased by 3 to 5 times compared to mdx5cv. Consequently, mdx5cv-JAG1 muscles were significantly bigger and stronger than dystrophic controls, along with an increased number of myofibers. Proteomics data show increased dysferlin in mdx5cv-JAG1 muscles and an association of the histone methyltransferase Nsd1 with the phenotype. Our data support the positive effect of JAG1 overexpression in dystrophic muscles.

Keywords: Duchenne muscular dystrophy; Jagged-1; genetic modifier; mouse model; physiology.

PubMed Disclaimer

Conflict of interest statement

Competing interests statement:L.M.K. is on the scientific advisory board of Dyne, Myofinity, Somite, and Elenae Therapeutics. He also consults with Advertent Biotherapeutics and PeterBio. M.R.L. became an employee of Vertex Pharmaceuticals at the time of the paper’s submission. T.Y.Z. is an employee of Sanofi.

Update of

References

    1. Koenig M., et al. , Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50, 509–517 (1987). - PubMed
    1. Hoffman E. P., Brown R. H. Jr., Kunkel L. M., Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51, 919–928 (1987). - PubMed
    1. Emery A. E., Population frequencies of inherited neuromuscular diseases–A world survey. Neuromuscul. Disord. 1, 19–29 (1991). - PubMed
    1. Broomfield J., Hill M., Guglieri M., Crowther M., Abrams K., Life expectancy in Duchenne muscular dystrophy. Neurology 97, e2304–e2314 (2021). - PMC - PubMed
    1. Pegoraro E., et al. , SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy. Neurology 76, 219–226 (2011). - PMC - PubMed

MeSH terms

LinkOut - more resources